Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.14 (
ATP synthase
)
7,042
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Repeated extraction of bovine heart submitochondrial particles with ammonia and EDTA (AE) yields a preparation that is highly deficient in coupling
factor B
(FB). The activity of the thrice extracted particle (AE-P3) in ATP-driven NAD+ reduction by succinate and the 32Pi-ATP exchange activity were substantially stimulated, 8-fold and 5-fold, respectively, by purified FB. To decrease the basal activity of the particle further, the residual FB in AE-P3 was inactivated by treatment with the -SH reagent, 4-vinylpyridine. The resulting particle was depleted of F1 by treatment with 3.5 M NaBr. This particle was incorporated into asolectin liposomes alone and in the presence of added FB. Passive proton conduction in the FB-deficient proteoliposomes was negligible and restored in the presence of FB. The H+ conductance was inhibited extensively by oligomycin and partially by
F1-ATPase
. The results show absolute dependence on FB for functioning of the FO proton channel.
...
PMID:Coupling factor B is a component of the Fo proton channel of mitochondrial H+-ATPase. 243 94
Mitochondrial H+ -ATPase complex, purified by the lysolecithin extraction procedure, has been resolved into a "membrane" (NaBr-F0) and a "soluble" fraction by treatment with 3.5 M sodium bromide. The NaBr-F0 fraction is completely devoid of beta, delta, and epsilon subunits of the F, ATPase and largely devoid of alpha and gamma subunits of F1, where F0 is used to denote the membrane fraction and F1, coupling factor 1. This is confirmed by complete loss of ATPase and Pi-ATP exchange activities. The addition of F1 (400 micrograms X mg-1 F0) results in complete restoration of oligomycin sensitivity without any reduction in the
F1-ATPase
activity. Presumably, this is due to release of ATPase inhibitor protein from the F1-F0 complex consequent to sodium bromide extraction. Restoration of Pi-ATP exchange and H+ -pumping activities require coupling
factor B
in addition to
F1-ATPase
. The oligomycin-sensitive ATPase and 32Pi-ATP exchange activities in reconstituted F1-F0 have the same sensitivity to uncouplers and energy transfer inhibitors as in starting submitochondrial particles from the heavy layer of mitochondria and F1-F0 complex. The data suggest that the altered properties of NaBr-F0 observed in other laboratories are probably inherent to their F1-F0 preparations rather than to sodium bromide treatment itself. The H+ -ATPase (F1-F0) complex of all known prokaryotic (3, 8, 9, 10, 21, 32, 34) and eukaryotic (11, 26, 30, 33, 35-37) phosphorylating membranes contain two functionally and structurally distinct entities. The hydrophilic component F1, composed of five unlike subunits, shows ATPase activity that is cold labile as well as uncoupler- and oligomycin-insensitive. The membrane-bound hydrophobic component F0, having no energy-linked catalytic activity of its own, is indirectly assayed by its ability to regain oligomycin sensitive ATPase and Pi-ATP exchange activities on binding to
F1-ATPase
(33). The purest preparations of bovine heart mitochondrial F0 show seven or eight major components in polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate or SDS-PAGE (1, 2, 12, 14), ranging from 6 to 54 ku in molecular weight (12). The precise structure and polypeptide composition of mitochondrial F0 is not known. The F0 preparations from bovine heart reported so far have been derived from H+ -ATPase preparations isolated in the presence of cholate and deoxycholate (11, 33, 36, 37).(ABSTRACT TRUNCATED AT 400 WORDS)
...
PMID:Resolution and reconstitution of H+ -ATPase complex from beef heart mitochondria. 285 48
Membrane energization by ATP has been measured in vesicles containing purified bovine heart mitochondrial H+-ATPase (
ATP synthase
) with the voltage-sensitive dye oxonol VI. The dithiol chelator, Cd2+, and the thiol oxidant, copper o-phenanthroline, produced discharge of the membrane potential when added at the steady state and inhibited its establishment when added prior to energization by ATP. These effects, which were reversed by dithiothreitol, were not accompanied by an increase in the nonspecific H+ permeability of the membrane. Passive H+ conduction in proteoliposomes containing F0 (hydrophobic segment of
ATP synthase
) was assayed by the quenching of 9-aminoacridine fluorescence after establishing a K+ diffusion potential. This conductance was blocked by Cd2+, an inhibitor of coupling
factor B
(FB). Labeling of F0 with 115Cd2+ at the concentrations that inhibited the F0 conductance followed by gel electrophoresis yielded a single radioactive band with a molecular weight corresponding to FB, the presence of which in the F0 preparation was confirmed by immunoblot staining. The data offer strong evidence that FB is an essential component of the H+ channel of F0, because H+ conduction through the channel is inhibited by chemical modification of FB.
...
PMID:Evidence for the involvement of coupling factor B in the H+ channel of the mitochondrial H+-ATPase. 614 19
Three apparently different modifications of submitochondrial particles (SMP) or
ATP synthase
preparations (complex V) inhibit oxidative phosphorylation and ATP-32Pi exchange activities, all of which are reversible by addition of mono- or dithiols. (a) Triphenyltin chloride inhibits ATP synthesis and hydrolysis without uncoupling. The inhibition by triphenyltin chloride is reversible by addition of beta-mercaptoethanol, dithiothreitol, or dihydrolipoamide. (b) Factor B is a water-soluble protein of Mr (11-12) X 10(3), contains a vicinal dithiol, and is required for energy transfer to and from
F1-ATPase
when tested with SMP-rendered
factor B
deficient by extraction with ammonia-ethylenediaminetetraacetic acid (EDTA) (AE-SMP). Treatment of
factor B
with mono- and dithiol modifiers, such as p-(chloromercuri)benzenesulfonate (PCMPS), Cd2+, or diazenedicarboxylic acid bis(dimethylamide) (diamide), inhibits
factor B
. This inhibition is reversed by addition to modified
factor B
of appropriate mono- and dithiol compounds. Preparations of AE-SMP are partially F1 deficient and partially uncoupled. The uncoupling can be repaired completely by addition of
factor B
or low levels of oligomycin, or to a large extent by addition of
F1-ATPase
+ oligomycin sensitivity conferring protein. (c) SMP, AE-SMP, and complex V can be completely uncoupled by treatment at 30 degrees C with phenylarsine oxide, Cd2+, diamide, PCMPS, monobromobimane, and mono- and bifunctional maleimides. The uncoupling by these reagents is potentiated by membrane energization. Uncoupling by diamide is greater than or equal to 80% reversed by dihydrolipoamide or beta-mercaptoethanol, the former being much more potent. Dithiothreitol and dithioerythritol are poorly effective.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Thiols in oxidative phosphorylation: inhibition and energy-potentiated uncoupling by monothiol and dithiol modifiers. 647 76
Factor B is a subunit of the mammalian
ATP synthase
complex, whose existence has been controversial. This paper describes the molecular and functional properties of a recombinant human
factor B
, which when added to bovine submitochondrial particles depleted of their
factor B
restores the energy coupling activity of the
ATP synthase
complexes. The mature human
factor B
has 175 amino acids and a molecular mass of 20,341 Da. The preparation is water-soluble, monomeric, and is inactivated by monothiol- and especially dithiol-modifying reagents, probably reacting at its cysteine residues Cys-92 and Cys-94. A likely
factor B
gene composed of 5 exons has been identified on chromosome 14q21.3, and the functional role of
factor B
in the mammalian
ATP synthase
complex has been discussed.
...
PMID:Factor B and the mitochondrial ATP synthase complex. 1174 38
Factor B is a water-soluble protein, which is required for the coupled activity of the mitochondrial
ATP synthase
complex. Specific removal of
factor B
from well-coupled bovine heart submitochondrial particles (SMP) results in uncoupling and the loss of ATP-driven membrane potential formation and reverse electron transfer from succinate to NAD. Addition of recombinant human
factor B
(molecular mass 20,341 Da) to
factor B
-depleted SMP (AE-SMP) restores these properties [G.I. Belogrudov, and Y. Hatefi, (2002) J. Biol. Chem. 277, 6097-6103]. This paper shows that extraction and purification of
ATP synthase
complex (complex V) from bovine heart mitochondria results in extensive loss of
factor B
. Addition of recombinant human
factor B
to AE-SMP completely restores the lost oxidative phosphorylation and ATP-32P(i) exchange activities of the particles and increases the ATP-32P(i) exchange activity of complex V by 2.5-fold. These results further indicate that
factor B
is an essential component of the mammalian
ATP synthase
complex.
...
PMID:Factor B is essential for ATP synthesis by mitochondria. 1236 15
Bovine
factor B
, a polypeptide required for the coupled activity of the mitochondrial
ATP synthase
complex, was cloned. A novel expression system for overproducing the recombinant bovine
factor B
was developed, which yielded the recombinant polypeptide at a level of 12-15 mg of protein per liter of bacterial culture. Reconstitution of the recombinant polypeptide with
factor B
-depleted ammonia, EDTA-treated submitochondrial particles (AE-SMP) restored the formation of substrate-driven DeltapH gradient across vesicular membranes, presumably by blocking a proton leak. The proton leak in the AE-SMP could also be blocked by the F0 inhibitors oligomycin and dicyclohexylcarbodiimide, but not the
F1-ATPase
inhibitors efrapeptin and aurovertin B. The six
factor B
thiols titrated rapidly with Ellman's reagent, and two of these, presumably Cys92 and Cys94, gained protection following treatment of
factor B
with a vicinal dithiol-specific reagent phenylarsine oxide (PAO). Similarly, Cd2+, whose binding to
factor B
is believed to also involve a vicinal dithiol, and PAO, protected approximately 2 Cys residues against labeling with sulfhydryl-specific fluorescent reagent fluorescein-5'-maleimide. The circular dichroism spectra showed that binding of Cd2+ and Zn2+, but not Ca2+ to bovine
factor B
caused small but reproducible changes in the secondary structure elements of the polypeptide.
...
PMID:Bovine factor B: cloning, expression, and characterization. 1657 55
Since the early studies on the resolution and reconstitution of the oxidative phosphorylation system from animal mitochondria, coupling
factor B
was recognized as an essential component of the machinery responsible for energy-driven ATP synthesis. At the phenomenological level,
factor B
was agreed to lie at the interface of energy transfer between the respiratory chain and the
ATP synthase
complex. However, biochemical characterization of the
factor B
polypeptide has proved difficult. It was not until 1990 that the N-terminal amino acid sequence of bovine mitochondrial
factor B
was reported, which followed, a decade later, by the report describing the amino acid sequence of full-length human
factor B
and its functional characterization. The present review summarizes the recent advances in structure-functional studies of
factor B
, including its recently determined crystal structure at 0.96 A resolution. Ectopic expression of human
factor B
in cultured animal cells has unexpectedly revealed its role in shaping mitochondrial morphology. The supramolecular assembly of
ATP synthase
as dimer ribbons at highly curved apices of the mitochondrial cristae was recently suggested to optimize ATP synthesis under proton-limited conditions. We propose that the binding of the
ATP synthase
dimers with
factor B
tetramers could be a means to enhance the efficiency of the terminal step of oxidative phosphorylation in animal mitochondria.
...
PMID:Recent advances in structure-functional studies of mitochondrial factor B. 1937 34